|
“Missed Germline Pathogenic Mutations: Causes, Consequences & Corrective Actions" |
04/23/2018 - 12:00pm to 1:00pm |
|
“Liposarcoma: New Insights into Subtypes and New Treatment Directions” and “From Clonal Hematopoiesis to Hematologic Malignancy: Determining the Causes of Transformation” |
03/26/2018 - 12:00pm to 1:00pm |
|
“Identifying Cancer Patients at High Risk for ER Visits and Hospitalizations: The Supportive Oncology Screener” and “Acute Promyelocytic Leukemia: Induction Therapy for the High Risk Patient” |
10/16/2017 - 12:00pm to 1:00pm |
|
“Hypomethylating Agents in AML: Understanding Practice Patterns and Enhancing Therapeutic Benefit” and “Immune Related Adverse Events: When to Refer” |
10/09/2017 - 12:00pm to 1:00pm |
|
“Hepatocellular Carcinoma: Treatment Challenges and the Landscape of Investigational Therapeutics” |
09/11/2017 - 12:00pm to 1:00pm |
|
“Exploring Preneoplastic Progression and Heterogeneity of Lung, and Head & Neck Malignancies” |
03/12/2018 - 12:00pm to 1:00pm |
|
“Evolving Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Myeloma” and “Defining Response: A Closer Look at Biomarkers to Predict Response to Checkpoint Blockade in Solid Tumors” |
06/25/2018 - 12:00pm to 1:00pm |
|
“Enhancing the Immune Response in Non-Small Cell Lung Cancer” and “Targeting Cellular Metabolism Through Modulation of BACH1 in Triple Negative Breast Cancer ” |
10/02/2017 - 12:00pm to 1:00pm |
|
“EGFR Mutation-Positive Lung Cancer in 2018” |
05/14/2018 - 12:00pm to 1:00pm |
|
“Drug De-Development: An Opportunity to Reduce Costs of Cancer Care” |
05/07/2018 - 12:00pm to 1:00pm |
Facebook
Twitter
LinkedIn
Forward